Neuropathix Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Neuropathix last-minute Real Value cannot be determined due to lack of data. The latest price of Neuropathix is $0.0. Our model forecasts the value of Neuropathix from analyzing the firm fundamentals such as Return On Asset of -3.08, shares owned by insiders of 23.54 %, and Current Valuation of 3.45 M as well as examining its technical indicators and probability of bankruptcy. . In general, most investors recommend acquiring undervalued stocks and dropping overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Neuropathix Total Value Analysis
Neuropathix is now anticipated to have valuation of 3.45 M with market capitalization of 18.76 K, debt of 484.28 K, and cash on hands of 102.19 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Neuropathix fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.45 M | 18.76 K | 484.28 K | 102.19 K |
Neuropathix Asset Utilization
One of the ways to look at asset utilization of Neuropathix is to check how much profit was generated for every dollar of assets it reports. Neuropathix secures a negative usage of assets of -3.08 %, losing $0.0308 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Neuropathix shows how discouraging it operates for each dollar spent on its assets.Neuropathix Ownership Allocation
Neuropathix maintains a total of 93.81 Million outstanding shares. Neuropathix holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Neuropathix Profitability Analysis
Net Loss for the year was (3.56 M) with loss before overhead, payroll, taxes, and interest of (268.3 K).Neuropathix Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 91.1 M | |
| Retained Earnings | -16.6 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Neuropathix OTC Stock
If you are still planning to invest in Neuropathix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neuropathix's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |